HDL RECEPTOR SR B1--REGULATION AND ROLE
HDL RECEPTOR SR B1--REGULATION AND ROLE
批准号:
6139269
负责人:
Deneys Rem Van Der Westhuyzen
金额:
$15.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2001-12-31
关键词:
Adenoviridae CHO cells RNA splicing amyloid proteins apolipoproteins atherosclerosis blood lipoprotein metabolism blood lipoprotein transport cholesterol gel filtration chromatography genetically modified animals high density lipoproteins human tissue inflammation laboratory mouse liver cells phospholipase A2 receptor receptor binding receptor expression tissue /cell culture transfection
中文摘要
描述(改编自申请人摘要):血浆HDL水平是
与动脉粥样硬化的风险呈负相关。 HDL或
清道夫受体-B1(SR-B1)是最近描述的质膜
介导高密度脂蛋白胆固醇选择性递送的高密度脂蛋白受体
酯到细胞。 首席研究员已经证明,
SR-B1 mRNA的剪接发生在人和小鼠的组织中,
这是未知的。 SR-B1已被定位到与HDL相关的位点
未发表的评论(Unpublished Observations) 炎症诱导多种多样的
代谢变化,其中两个特别导致HDL的调节
结构和代谢。 诱导的急性期血清淀粉样蛋白A(SAA)
置换载脂蛋白A-I并显著重塑HDL颗粒。
另一种急性时相蛋白,分泌型非胰腺磷脂酶A2
(sPLA 2)是伴随诱导的,并且可以水解HDL磷脂。 的
在这个建议中要检验的中心假设是,
在炎症过程中发生的HDL的变化导致了
HDL和SR-B1之间的相互作用。 这些变化将具有重要意义。
影响HDL代谢,并可能影响HDL介导的胆固醇
递送到肝脏以及HDL和细胞之间的胆固醇通量,
局限性动脉粥样硬化病变。
本建议的具体目标是:1)确定
选择性mRNA剪接在调节和功能活性的作用
SR-B1 这将通过量化不同基因的表达来实现。
在调节SR-B1的条件下SR-B1 mRNA和蛋白的形式
表达和通过在培养的细胞中表达不同形式的SR-B1
并比较它们作为HDL受体的功能; 2)确定如何
炎症诱导的HDL修饰影响HDL与SR-B1的结合
受体和选择性脂质摄取进入细胞。 为实现这些目标将
确定急性期反应期间HDL的改变或
通过sPLA 2和SAA的特异性修饰,改变HDL与SR-B1的结合,或
SR-B1介导的脂质向细胞的递送;和3)确定SR-B1介导的脂质向细胞的递送的程度。
SR-B1在小鼠中的表达影响了正常和
急性期HDL。 这将通过确定
腺病毒介导的SR-B1在正常和
急性期HDL和其他脂蛋白。
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Plasma HDL levels are
inversely associated with the risk for atherosclerosis. The HDL or
scavenger receptor-B1 (SR-B1) is a recently-described plasma membrane
receptor for HDL that mediates the selective delivery of HDL cholesterol
ester to cells. The principal investigator has shown that alternative
splicing of SR-B1 mRNA occurs in man and mouse tissues, the relevance of
which is unknown. SR-B1 has been mapped to a locus associated with HDL
levels (unpublished observations). Inflammation induces a wide variety of
metabolic changes and two of these in particular lead to modulation of HDL
structure and metabolism. The induced acute phase serum amyloid A (SAA)
displaces apolipoprotein A-I and markedly remodels the HDL particle.
Another acute phase protein, secretory non-pancreatic phospholipase A2
(sPLA2) is concomitantly induced and can hydrolyze HDL phospholipids. The
central hypothesis to be examined in this proposal is that the modification
of HDL that occurs during inflammation leads to alterations in the
interaction between HDL and SR-B1. Such changes would have important
implications for HDL metabolism and could affect HDL-mediated cholesterol
delivery to the liver as well as cholesterol flux between HDL and cells in
localized atherosclerotic lesions.
The specific aims of this proposal are: 1) determine the significance of
alternative mRNA splicing in the regulation and functional activity of
SR-B1. This will be achieved by quantifying the expression of the different
forms of SR-B1 mRNA and protein under conditions that regulate SR-B1
expression and by expressing the different forms of SR-B1 in cultured cells
and comparing their abilities to function as HDL receptors; 2) determine how
inflammation-induced modifications of HDL influence HDL binding to the SR-B1
receptor and selective lipid uptake into cells. This will be achieved by
determining whether modifications of HDL during an acute phase response or
modification by sPLA2 and SAA specifically, alters HDL binding to SR-B1 or
SR-B1-mediated lipid delivery to cells; and 3) determine the extent to which
SR-B1 expression in the mouse influences the plasma levels of normal and
acute phase HDL. This will be achieved by determining the effect of
adenovirus-mediated over-expression of SR-B1 on the levels of normal and
acute phase HDL and of other lipoproteins.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
2001-08
期刊:
Journal of lipid research
影响因子:
6.5
作者:
[W. D. Villiers;Lei Cai;N. Webb;M. Beer;D. Westhuyzen;F. D. Beer]
通讯作者:
W. D. Villiers;Lei Cai;N. Webb;M. Beer;D. Westhuyzen;F. D. Beer
The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake.
SR-BI 介导的选择性脂质摄取后 HDL 颗粒在体内的命运。
DOI:
10.1194/jlr.m200173-jlr200
发表时间:
2002
期刊:
Journal of lipid research
影响因子:
6.5
作者:
[Webb,NancyR, Cai,Lei, Ziemba,KristineS, Yu,Jin, Kindy,MarkS, vanderWesthuyzen,DeneysR, deBeer,FrederickC]
通讯作者:
deBeer,FrederickC
Class B Scavenger Receptors and Atherosclerosis
-
批准号:7798400
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
Class B Scavenger Receptors and Atherosclerosis
-
批准号:8391579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
Class B Scavenger Receptors and Atherosclerosis
-
批准号:7904139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
Class B Scavenger Receptors and Atherosclerosis
-
批准号:8195617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
HDL Function and Metabolism During Inflammation
-
批准号:7586667
-
项目类别:
-
资助金额:$141.24万
-
财政年份:2007
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
HDL Function and Metabolism During Inflammation
-
批准号:7793418
-
项目类别:
-
资助金额:$141.98万
-
财政年份:2007
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
HDL Function and Metabolism During Inflammation
-
批准号:7184075
-
项目类别:
-
资助金额:$147.77万
-
财政年份:2007
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
HDL Function and Metabolism During Inflammation
-
批准号:7406817
-
项目类别:
-
资助金额:$141.63万
-
财政年份:2007
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
HDL Function and Metabolism During Inflammation
-
批准号:8049664
-
项目类别:
-
资助金额:$141.98万
-
财政年份:2007
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
Inflammation, HDL and class B Scavenger Rectors
-
批准号:7219727
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2006
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
Administrative Core
-
批准号:7219729
-
项目类别:
-
资助金额:$5.68万
-
财政年份:2006
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
SR-BI: INFLUENCE OF APOA-II
-
批准号:6390556
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
CLASS B SCAVENGER RECEPTORS AND FOAM CELL FORMATION
-
批准号:6194115
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
CLASS B SCAVENGER RECEPTORS AND FOAM CELL FORMATION
-
批准号:6390893
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
SR-BI: INFLUENCE OF APOA-II
-
批准号:6527243
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
SR-BI: INFLUENCE OF APOA-II
-
批准号:6642686
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
SR-BI: INFLUENCE OF APOA-II
-
批准号:6193761
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
CLASS B SCAVENGER RECEPTORS AND FOAM CELL FORMATION
-
批准号:6656305
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
CLASS B SCAVENGER RECEPTORS AND FOAM CELL FORMATION
-
批准号:6527650
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
SR-BI and SR-BII recycling and selective lipid uptake
-
批准号:7471366
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2000
-
负责人:Deneys Rem Van Der Westhuyzen
-
依托单位:
海外基金